Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma

Clinical trial NCT02731313 · COMPLETED

Trial details

NCT number: NCT02731313
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Gastric Cancer, Gastroesophageal Junction Cancer

Start date: 2012-07-01
Primary completion: 2014-10-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.